Android app on Google Play

Barclays Takes More Conservative Tone on Tempur-Pedic (TPX); Cutting Price Target As Competitive Forces Change

May 7, 2012 1:20 PM EDT Send to a Friend
Get Alerts TPX Hot Sheet
Price: $50.83 +1.82%

Rating Summary:
    5 Buy, 8 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 26 | Down: 10 | New: 8
Trade TPX Now!
Join SI Premium – FREE
Barclays maintains an 'Equalweight' on Tempur-Pedic (NYSE: TPX) price target lowered from $85 to $63.

Analyst, Jessics Schoen, said, "We are taking a more conservative stance on valuation for the following reasons: the intensifying competitive environment for specialty mattresses, uncertainty around potential cannibalization presented by the Simplicity launch, and tough compares as a result of very strong industry growth in the last year, particularly in the specialty segment."

For an analyst ratings summary and ratings history on Tempur-Pedic click here. For more ratings news on Tempur-Pedic click here.

Shares of Tempur-Pedic closed at $56.71 yesterday.




You May Also Be Interested In


Related Categories

Analyst Comments, Analyst PT Change

Related Entities

Barclays

Add Your Comment